SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IVAX, Generic Giant
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Doug who wrote (198)5/13/1997 8:45:00 PM
From: MD Payne   of 212
 
IVAX featured in SMART MONEY Magazine - June 1997 Edition - Article states that a top ranked healthcare analyst (Hemant Shah of HKS & Co.) gives an estimate of:
$ 8.50 for Ivax's Continental Arm
$ 3.40 for McGaw Intraveneous Branch
$10.00 for Everything Else
-------------------------- Total Value Almost $22.00 per Share

Shah also says the stock could easily return to the mid 20's

Doug, Just Received and Wish to Share with You and Fellow Shareholders

Thanks,

M D Payne
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News